Nutex Health Inc reports results for the quarter ended in June - Earnings Summary

Reuters08-09

* Nutex Health Inc reported a quarterly adjusted loss of 7 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-1.50. The lone analyst forecast for the quarter was for a loss of 29 cents per share.

* Revenue rose 29.1% to $76.08 million from a year ago; analysts expected $68.20 million.

* Nutex Health Inc's reported EPS for the quarter was a loss of 7 cents.

* The company reported a quarterly loss of $364 thousand.

* Nutex Health Inc shares had risen by 31.6% this quarter and lost 71.0% so far this year.

FORECAST CHANGES

* In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Nutex Health Inc is $30.00 This summary was machine generated from LSEG data August 8 at 10:12 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Jun. 30 2024 -0.29 -0.07 Beat

Mar. 31 2024 0.00 -0.60 Missed

Dec. 31 2023 0.00 0.00 Met

Sep. 30 2023 -0.75 -1.50 Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2458379618?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-09 06:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2458379618","market":"us","top_or_hot":-1,"title":"Nutex Health Inc reports results for the quarter ended in June - Earnings Summary","media":"Reuters","content":"<html><body><p>* <a href=\"https://laohu8.com/S/NUTX\">Nutex Health Inc</a>    reported a quarterly adjusted loss of 7 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-1.50.  The lone analyst forecast for the quarter was for a loss of 29 cents per share. </p><p>   * Revenue rose 29.1% to $76.08 million from a year ago; analysts expected $68.20 million. </p><p>   * Nutex Health Inc's reported EPS for the quarter was a loss of 7 cents.</p><p>   * The company reported a quarterly loss of $364 thousand.</p><p>   * Nutex Health Inc shares had risen by 31.6% this quarter and lost 71.0% so far this year.</p><p>FORECAST CHANGES</p><p>   * In the last 30 days, one analyst negatively revised an earnings estimate</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the healthcare facilities &amp; services peer group is also \"buy\"</p><p>Wall Street's median 12-month price target for Nutex Health Inc is $30.00  This summary was machine generated from LSEG data August 8 at 10:12 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Jun. 30 2024      -0.29          -0.07          Beat</p><p>Mar. 31 2024      0.00           -0.60          Missed</p><p>Dec. 31 2023      0.00           0.00           Met</p><p>Sep. 30 2023      -0.75          -1.50          Missed</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nutex Health Inc reports results for the quarter ended in June - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNutex Health Inc reports results for the quarter ended in June - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-09 06:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Nutex Health Inc    reported a quarterly adjusted loss of 7 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-1.50.  The ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUTX","symbol_name":"Nutex Health Inc","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2458379618","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2458379618","pubTimestamp":1723155192,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Nutex Health Inc    reported a quarterly adjusted loss of 7 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-1.50.  The lone ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"NUTX":"Nutex Health Inc"},"translate_title":"Nutex Health Inc报告截至6月的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUTX":1},"content_text":"* Nutex Health Inc    reported a quarterly adjusted loss of 7 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $-1.50.  The lone analyst forecast for the quarter was for a loss of 29 cents per share.    * Revenue rose 29.1% to $76.08 million from a year ago; analysts expected $68.20 million.    * Nutex Health Inc's reported EPS for the quarter was a loss of 7 cents.   * The company reported a quarterly loss of $364 thousand.   * Nutex Health Inc shares had risen by 31.6% this quarter and lost 71.0% so far this year.FORECAST CHANGES   * In the last 30 days, one analyst negatively revised an earnings estimateRECOMMENDATIONS   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"    * The average consensus recommendation for the healthcare facilities & services peer group is also \"buy\"Wall Street's median 12-month price target for Nutex Health Inc is $30.00  This summary was machine generated from LSEG data August 8 at 10:12 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDJun. 30 2024      -0.29          -0.07          BeatMar. 31 2024      0.00           -0.60          MissedDec. 31 2023      0.00           0.00           MetSep. 30 2023      -0.75          -1.50          Missed","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458379618"}